.
en
Worldwide
ARSTIFEN
PHARMACEUTICAL FROM :
Tablets
ATC class :
Urinary concrement solvents.
Active substance :
citric acid anhydrous, trisodium citrate anhydrous, potassium hydrocarbonate
Composition :

1 tablet contains citric acid anhydrous 1197 mg; trisodium citrate anhydrous 835.5 mg; potassium hydrocarbonate 967.5 mg

Indications :

Arstifen® is used for the treatment of urinary stone disease with the purpose of:
• alkalization of urine in patients with urate stones, in the presence of concomitant calcium stones or without them;
• metaphysics of calcium-oxalate concretions (prevention of re-formation of new stones and/or growth of residual fragments).